Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: A study of the general population

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 10, 2012, Pages 975-981

  Lange, Peter ^a   Marott, Jacob Louis ^a   Vestbo, Jørgen ^b,c   Olsen, Kim Rose ^d   Ingebrigtsen, Truls Sylvan ^a   Dahl, Morten ^e,f   Nordestgaard, Børge Grønne ^a,f,g  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d GLAXOSMITHKLINE   (Denmark)

^e Rigshospitalet   (Denmark)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Comorbidities; COPD; Guidelines; Prognosis

Indexed keywords

PREDNISOLONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DYSPNEA; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 84869219097     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201207-1299OC     Document Type: Article

References (24)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: revised 2011. Available from: http://www.goldcopd.org/ uploads/users/files/GOLD-Report-2011-Jan21.pdf
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.AmJ Respir Crit Care Med 2007;176:532-555. (Pubitemid 47403272)
3. Lange P, Marott J, Dahl M, Ingebrigtsen TS, Vestbo J, Nordestgaard B. Predicting the natural course of COPD using the old and the new GOLD classification. Eur Respir J 2012 Suppl 56:278s.
4. Appleyard M, Hansen AT, Schnohr P, Jensen G, Nyboe J. The Copenhagen City Heart Study: a book of tables with data from the first examination (1976-78) and a five-year follow-up (1981-83). Scand J Soc Med 1989;170(Suppl 41):1-160.
5. Lange P, Mogelvang R, Marott JL, Vestbo J, Jensen JS. Cardiovascular morbidity in COPD: a study of the general population. COPD 2010;7:5-10.
6. Stender S, Frikke-Smidth R, Nordestgaard BG, Tybjærg-Hansen A. Sterol transporter adenosine triphosphate-binding cassette transporter G8, gallstones, and biliary cancer in 62,000 individuals from the general population. Hepatology 2011;53:640-648.
7. Danish National Patient Registry. Available from: http://www.sst.dk/ Indberetning%20og%20statistik/Landspatientregisteret
8. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-448. (Pubitemid 27382061)
9. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health, ATC/DDD Index 2010. Available from: http://www.whocc.no/atc-ddd-index/
10. Lange P, Marott JL, Dahl M, Ingebrigtsen TS, Vestbo J, Nordestgaard BG. Substantial need for early diagnosis, rehabilitation and treatment of COPD. Dan Med J 2012;59:A4396.
11. Ulrik CS, Løkke A, Dahl R, Dollerup J, Hansen G, Cording PH, Andersen KK; TOP Study Group. Early diagnosis of COPD in general practice. Int J Chron Obstruct Pulmon Dis 2011;6:123-127.
12. Hurst J, Vestbo J, Anzueto A, Locantore N, Mülerova H, Tal-Singer R, Miller B, Lomas D, Agusti A, MacNee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
13. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-1012. (Pubitemid 38269277)
14. Vestbo J, Knudsen KM, Rasmussen FV. Should we continue using questionnaires on breathlessness in epidemiologic surveys? Am Rev Respir Dis 1988;137:1114-1118.
15. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-yr survival than airway obstruction in patients with COPD. Chest 2002;121:1434-1440. (Pubitemid 34499652)
16. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-1894. (Pubitemid 41253302)
17. Brekke PH, Omland T, Smith P, Soyseth V. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 2008;102:1243-1247.
18. McAllister DA, Maclay JD, Mills NL, Leitch A, Reid P, Carruthers R, O'Connor J, McAlpine L, Chalmers G, Newby DE, et al. Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD. Eur Respir J 2012;39:1097-1103.
19. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J 2011;32:2365-2375.
20. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28:1245-1257. (Pubitemid 44883863)
21. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008;31:204-212.
22. Mannino DM, Doherty DE, Buist SA. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Respir Med 2006;100:115-122. (Pubitemid 43039873)
23. Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand 1983;214(Suppl 682):1-120.
24. Vestbo J, Sørensen T, Lange P, Torre P, Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999;353:1819-1823. (Pubitemid 29251012)